Multi-omics approaches to therapeutic target identification.
- Published in:
- Briefings in Functional Genomics, 2023, v. 22, n. 2, p. 75, doi. 10.1093/bfgp/elac058
- By:
- Publication type:
- Article
Works matching IS 20412649 AND DT 2023 AND VI 22 AND IP 2
Results: 13
1
2
Multi-omics therapeutic perspective on ACVR1 gene: from genetic alterations to potential targeting.
- Published in:
- Briefings in Functional Genomics, 2023, v. 22, n. 2, p. 123, doi. 10.1093/bfgp/elac026
- By:
- Publication type:
- Article
3
SARS-CoV-2 ORF8 dimerization and binding mode analysis with class I MHC: computational approaches to identify COVID-19 inhibitors.
- Published in:
- Briefings in Functional Genomics, 2023, v. 22, n. 2, p. 227, doi. 10.1093/bfgp/elac046
- By:
- Publication type:
- Article
4
Identification of therapeutic targets of gallbladder cancer using multi-omics approach.
- Published in:
- Briefings in Functional Genomics, 2023, v. 22, n. 2, p. 109, doi. 10.1093/bfgp/elac045
- By:
- Publication type:
- Article
5
Promoter–motif extraction from co-regulated genes and their relevance to co-expression using E. coli as a model.
- Published in:
- Briefings in Functional Genomics, 2023, v. 22, n. 2, p. 204, doi. 10.1093/bfgp/elac043
- By:
- Publication type:
- Article
6
Targeting novel sites in DNA gyrase for development of anti-microbials.
- Published in:
- Briefings in Functional Genomics, 2023, v. 22, n. 2, p. 180, doi. 10.1093/bfgp/elac029
- By:
- Publication type:
- Article
7
The regulatory role of non-coding RNAs and their interactions with phytochemicals in neurodegenerative diseases: a systematic review.
- Published in:
- Briefings in Functional Genomics, 2023, v. 22, n. 2, p. 143, doi. 10.1093/bfgp/elac055
- By:
- Publication type:
- Article
8
Tau–FG-nucleoporin98 interaction and impaired nucleocytoplasmic transport in Alzheimer's disease.
- Published in:
- Briefings in Functional Genomics, 2023, v. 22, n. 2, p. 161, doi. 10.1093/bfgp/elac022
- By:
- Publication type:
- Article
9
A comprehensive protein design protocol to identify resistance mutations and signatures of adaptation in pathogens.
- Published in:
- Briefings in Functional Genomics, 2023, v. 22, n. 2, p. 195, doi. 10.1093/bfgp/elac020
- By:
- Publication type:
- Article
10
Diversity and novel mutations in membrane transporters of Mycobacterium tuberculosis.
- Published in:
- Briefings in Functional Genomics, 2023, v. 22, n. 2, p. 168, doi. 10.1093/bfgp/elac018
- By:
- Publication type:
- Article
11
Multiomics technologies: role in disease biomarker discoveries and therapeutics.
- Published in:
- Briefings in Functional Genomics, 2023, v. 22, n. 2, p. 76, doi. 10.1093/bfgp/elac017
- By:
- Publication type:
- Article
12
Comprehensive omics studies of p53 mutants in human cancer.
- Published in:
- Briefings in Functional Genomics, 2023, v. 22, n. 2, p. 97, doi. 10.1093/bfgp/elac015
- By:
- Publication type:
- Article
13
Biophysical and modeling-based approach for the identification of inhibitors against DOHH from Leishmania donovani.
- Published in:
- Briefings in Functional Genomics, 2023, v. 22, n. 2, p. 217, doi. 10.1093/bfgp/elac014
- By:
- Publication type:
- Article